148 related articles for article (PubMed ID: 11274729)
21. [Effects of CCR5-delta32, CCR2-64I and SDF-1-3'A polymorphic alleles on human immunodeficiency virus 1 (HIV-1) infection in the Polish population].
Wasik TJ; Smoleń J; Kruszyński P; Bratosiewicz-Wasik J; Beniowski M
Wiad Lek; 2005; 58(9-10):500-7. PubMed ID: 16529059
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of a 32 bp deletion in the gene for human immunodeficiency virus 1 co-receptor CCR5 in Slovak population.
Takácová M; Nogová P; Hábeková M; Staneková D
Acta Virol; 2008; 52(4):261-4. PubMed ID: 19143484
[TBL] [Abstract][Full Text] [Related]
23. Frequency of the delta ccr5 deletion allele in the urban Brazilian population.
Passos GA; Picanço VP
Immunol Lett; 1998 Apr; 61(2-3):205-7. PubMed ID: 9657277
[TBL] [Abstract][Full Text] [Related]
24. CCR5 genotype and plasma beta-chemokine concentration of Brazilian HIV-infected individuals.
Mikawa AY; Tagliavini SA; Costa PI
Braz J Med Biol Res; 2002 Nov; 35(11):1333-7. PubMed ID: 12426633
[TBL] [Abstract][Full Text] [Related]
25. Polymorphisms in CCR5Δ32 and Risk of HIV-1 Infection in the Southeast of Caspian Sea, Iran.
Heydarifard Z; Tabarraei A; Moradi A
Dis Markers; 2017; 2017():4190107. PubMed ID: 29209099
[TBL] [Abstract][Full Text] [Related]
26. Frequency of CCR5-Delta32 deletion in human immunodeficiency virus type 1 (HIV-1) in healthy blood donors, HIV-1-exposed seronegative and HIV-1-seropositive individuals of southern Brazilian population.
Reiche EM; Ehara Watanabe MA; Bonametti AM; Morimoto HK; Akira Morimoto A; Wiechmann SL; Matsuo T; Carvalho De Oliveira J; Vissoci Reiche F
Int J Mol Med; 2008 Nov; 22(5):669-75. PubMed ID: 18949389
[TBL] [Abstract][Full Text] [Related]
27. Beyond HIV infection: Neglected and varied impacts of CCR5 and CCR5Δ32 on viral diseases.
Ellwanger JH; Kulmann-Leal B; Kaminski VL; Rodrigues AG; Bragatte MAS; Chies JAB
Virus Res; 2020 Sep; 286():198040. PubMed ID: 32479976
[TBL] [Abstract][Full Text] [Related]
28. Resistance to Human Immunodeficiency Virus 1 Infection Conferred by a Compound CCR5Δ32 and CCR5 C20S Heterozygote.
Alkhatib B; Jabari M; Bilasy S; Abdul-Rahman H; Sandhu K; Lai S; Alkhatib G
J Infect Dis; 2023 Jul; 228(2):116-121. PubMed ID: 36912158
[TBL] [Abstract][Full Text] [Related]
29. Prevalence of mutant CCR5 allele in Slovenian HIV-1-infected and non-infected individuals.
Poljak M; Tomazic J; Seme K; Maticic M; Vidmar L
Acta Virol; 1998 Feb; 42(1):23-6. PubMed ID: 9645239
[TBL] [Abstract][Full Text] [Related]
30. CCR5Δ32 in Brazil: Impacts of a European Genetic Variant on a Highly Admixed Population.
Kulmann-Leal B; Ellwanger JH; Chies JAB
Front Immunol; 2021; 12():758358. PubMed ID: 34956188
[TBL] [Abstract][Full Text] [Related]
31. Potential role of CCR5 polymorphism in the development of AIDS dementia complex.
Boven LA; van der Bruggen T; van Asbeck BS; Marx JJ; Nottet HS
FEMS Immunol Med Microbiol; 1999 Dec; 26(3-4):243-7. PubMed ID: 10575135
[TBL] [Abstract][Full Text] [Related]
32. Frequency of CCR5Δ32 allele in healthy Bosniak population.
Adler G; Valjevac A; Skonieczna-Żydecka K; Mackic-Djurovic M; Parczewski M; Urbańska A; Salkic NN
Bosn J Basic Med Sci; 2014 Aug; 14(3):150-4. PubMed ID: 25172974
[TBL] [Abstract][Full Text] [Related]
33. Distribution of CCR5 genotypes and HLA Class I B alleles in HIV-1 infected and uninfected injecting drug users from Rio de Janeiro, Brazil.
Teixeira SL; Bastos FI; Hacker MA; Morgado MG
Infect Genet Evol; 2009 Jul; 9(4):638-42. PubMed ID: 19460331
[TBL] [Abstract][Full Text] [Related]
34. [Genetic polymorphism of human immunodeficiency virus coreceptor CCR5Delta32 and CCR2-64I alleles in Chinese Yi Ethnic group in Sichuan].
Deng XL; Hong KX; Chen JP; Ruan YH; Xu MY; Qin GM; Li K; Xing H; Shao YM
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Dec; 25(12):1050-3. PubMed ID: 15769362
[TBL] [Abstract][Full Text] [Related]
35. TALENs-mediated homozygous CCR5Δ32 mutations endow CD4+ U87 cells with resistance against HIV‑1 infection.
Yu AQ; Ding Y; Lu ZY; Hao YZ; Teng ZP; Yan SR; Li DS; Zeng Y
Mol Med Rep; 2018 Jan; 17(1):243-249. PubMed ID: 29115572
[TBL] [Abstract][Full Text] [Related]
36. Frequency of the CCR5 delta 32 mutant allele in HIV-1-positive patients, female sex workers, and a normal population in Taiwan.
Li C; Yan YP; Shieh B; Lee CM; Lin RY; Chen YM
J Formos Med Assoc; 1997 Dec; 96(12):979-84. PubMed ID: 9444918
[TBL] [Abstract][Full Text] [Related]
37. Cysteine-cysteine chemokine receptor 5 (CCR5) profile of HIV-infected subjects attending University of Calabar Teaching Hospital, Calabar, Southern Nigeria.
Ekere EF; Useh MF; Okoroiwu HU; Mirabeau TY
BMC Infect Dis; 2020 Jan; 20(1):5. PubMed ID: 31900106
[TBL] [Abstract][Full Text] [Related]
38. Gene polymorphisms in CCR5, CCR2, SDF1 and RANTES among Chinese Han population with HIV-1 infection.
Li H; Liu TJ; Hong ZH
Infect Genet Evol; 2014 Jun; 24():99-104. PubMed ID: 24650919
[TBL] [Abstract][Full Text] [Related]
39. CCR5 chemokine receptor genotype frequencies among Puerto Rican HIV-1-seropositive individuals.
Gonzalez S; Tirado G; Revuelta G; Yamamura Y; Lu Y; Nerurkar VR; Yanagihara R
Bol Asoc Med P R; 1998; 90(1-3):12-5. PubMed ID: 9734151
[TBL] [Abstract][Full Text] [Related]
40. Distribution of CCR5delta32, CCR2-64I and SDF1-3'A and plasma levels of SDF-1 in HIV-1 seronegative North Indians.
Verma R; Gupta RB; Singh K; Bhasin R; Anand Shukla A; Chauhan SS; Luthra K
J Clin Virol; 2007 Mar; 38(3):198-203. PubMed ID: 17240189
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
